Banner

GWAS-related eQTLs across different cancer types

We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions ( ≥ 0.5).



e.g., "STAD"
e.g., "r²>= 0.8"
e.g., "rs2273"
Cancer type
eQTL type
tagSNP
LD
SNP ID
SNP position (hg19)
Gene symbol
Gene position (hg19)
Beta
t-stat
p-value
GWAS-Traits
THCA cis rs3796352 1 rs6445557 chr3:53083969 RFT1 chr3:53122503-53164470:- -0.59 -7.99 1.0E-14 Immune reponse to smallpox (secreted IL-2)
THCA cis rs1031925 1 rs6445622 chr3:51356823 HEMK1 chr3:50606583-50622419:+ 0.2 4.18 3.4E-5 Melanoma
THCA cis rs1031925 1 rs6445622 chr3:51356823 TEX264 chr3:51705222-51738338:+ -0.22 -6.05 2.93E-9 Melanoma
THCA cis rs7647973 1 rs6446262 chr3:49401153 GMPPB chr3:49758932-49761384:- -0.17 -3.73 0.000218 Menarche (age at onset)
THCA cis rs7647973 1 rs6446262 chr3:49401153 P4HTM chr3:49027341-49044579:+ 0.19 4.65 4.33E-6 Menarche (age at onset)
THCA cis rs7647973 1 rs6446268 chr3:49445695 CCDC51 chr3:48473582-48481529:- -0.15 -3.59 0.00037 Menarche (age at onset)
THCA cis rs7647973 1 rs6446268 chr3:49445695 GMPPB chr3:49758932-49761384:- 0.17 3.85 0.000133 Menarche (age at onset)
THCA cis rs7647973 1 rs6446268 chr3:49445695 P4HTM chr3:49027341-49044579:+ -0.16 -3.99 7.6E-5 Menarche (age at onset)
THCA cis rs7647973 1 rs6446268 chr3:49445695 WDR6 chr3:49044637-49053386:+ 0.19 3.88 0.000121 Menarche (age at onset)
THCA cis rs7647973 1 rs6446275 chr3:49466871 GMPPB chr3:49758932-49761384:- 0.16 3.72 0.000221 Menarche (age at onset)
THCA cis rs7647973 1 rs6446275 chr3:49466871 P4HTM chr3:49027341-49044579:+ -0.17 -4.27 2.36E-5 Menarche (age at onset)
THCA cis rs7647973 1 rs6446275 chr3:49466871 WDR6 chr3:49044637-49053386:+ 0.18 3.69 0.000251 Menarche (age at onset)
THCA cis rs7438704 1 rs6447634 chr4:48413511 OCIAD1 chr4:48833015-48863831:+ -0.14 -4.21 3.0E-5 Crohn's disease;Inflammatory bowel disease
THCA cis rs6447650 1 rs6447650 chr4:40381210 CHRNA9 chr4:40337469-40356973:+ 0.32 3.36 0.000848 Body mass index (change over time)
THCA cis rs1949733 1 rs6447875 chr4:8503206 C4orf23 chr4:8440604-8495258:+ -0.35 -7.43 5.08E-13 Response to antineoplastic agents